Milestones
BrosMed Medical won a number of national high-tech professional certificates
So far
To be continued…
2026
Official opening of BrosMed’s new headquarters in Dongguan.
2025
Approved to establish a manufacturing facility in Malaysia, marking the beginning of BrosMed’s global manufacturing footprint.
Awarded the China Customs AEO Advanced Certification.
2024
Established a new operations center in the United States.
Recognized as a Guangdong Provincial Manufacturing Single Champion Enterprise and a National Key “Little Giant” Enterprise specializing in niche markets, innovation, and advanced technologies.
RevoEdge™ High Pressure Cutting Balloon Dilatation Catheter received both NMPA approval and CE Mark certification.
2023
Obtained CNAS Laboratory Accreditation Certificate.
Awarded the Gold Prize in the First Guangdong-Hong Kong-Macao Greater Bay Area (Guangdong) High-Value Trademark Brand Cultivation Program.
2020
BrosMed Medical completed its Series C financing round, led by Hillhouse Capital.
Wedge™ NC Scoring PTCA Balloon Dilatation Catheter received CE Mark certification.
Alveo™ HP Balloon Dilatation Catheter (Ø0.75mm) received CE Mark certification.
Tri-Wedge™ PTA Scoring Balloon Dilatation Catheter received CE Mark certification.
Multiple interventional accessories received CE Mark certification.
BrosMed was recognized as a Leading Enterprise in the Top 50 Innovative Biotechnology Companies in the Guangdong-Hong Kong-Macao Greater Bay Area (2020).
2019
Brun Medical Co., Ltd. was established.
BrosMed was recognized as a Leading Enterprise in the Top 50 Innovative Biotechnology Companies in the Guangdong-Hong Kong-Macao Greater Bay Area (2019).
BrosMed PTCA/PTA products were recognized as High-Tech Products of Guangdong Province.
BrosMed Medical received the High-Tech Enterprise Certificate.
2018
BrosMed Medical won the championship in the 2018 Dongguan Innovation and Entrepreneurship Competition.
2017
Artimes™ and Apollo™ PTCA Balloon Dilatation Catheters received PMDA approval, officially entering the Japanese market.
BrosMed entered into a strategic cooperation agreement with Cardinal Health.
Wedge™ SC Scoring PTCA Balloon Catheter received CE Mark certification.
2016
The BrosMed India subsidiary was established
Conger™ Hydrophilic Guide Wire received CE Mark certification.
Multiple PTA products received CE Mark certification.
2015
LEED International Co., Limited was established in Hong Kong.
2014
Apollo™ PTCA Balloon Dilatation Catheter received CE Mark certification.
BrosMed Medical B.V. was established in the Netherlands.
2013
BrosMed obtained ISO 13485 and ISO 9001 certifications.
Artimes™ Balloon Dilatation Catheter received CE Mark certification.
Brosmed Medical received the Special Award in the 2013 Dongguan Innovation and Entrepreneurship Competition.
2012
BrosMed Medical was founded in the Songshan Lake High-Tech Industrial Development Zone, Dongguan.